![Colleen DeSimone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Colleen DeSimone worked as the Chief Accounting Officer, VP-Finance & Controller at Syros Pharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she worked as the Secretary & Treasurer at Cedilla Therapeutics, Inc. Ms. DeSimone completed her undergraduate degree at Holy Cross College (Indiana).
Anciens postes connus de Colleen DeSimone
| Sociétés | Poste | Fin |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 09/03/2018 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Secrétaire Général | - |
Formation de Colleen DeSimone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Holy Cross College (Indiana)
 Holy Cross College (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Health Technology |
